NDXP250110P23925000
- 0.00
- 0.000.00%
NASDAQ 100 Index Newsroom
The Global Technology feast CES "money-making gift package" is coming! A summary of five major investment opportunities.
This year's largest Technology event has brought us many interesting new products. This article mainly reviews for mooers the major trends in consumer electronics investment focused on at the CES 2025.
U.S. stocks in the early market | All three major Indexes fell together! The Nasdaq dropped over 2%; Technology stocks suffered a heavy setback, with AMD dropping more than 5%; High-performing stocks surged against the trend! Pharmacy stock WBA rose over
On the evening of October 10 in Peking, US stocks opened lower on Friday. The surge in US bond yields put pressure on the stock indices, with the 30-year US bond yield rising to 5%. The non-farm payroll data for December significantly exceeded expectations, and the unemployment rate fell, leading investors to lower their expectations for a rate cut by the Federal Reserve.
Insights Into Netflix's Performance Versus Peers In Entertainment Sector
In-Depth Analysis: Tesla Versus Competitors In Automobiles Industry
Comparing Meta Platforms With Industry Competitors In Interactive Media & Services Industry
Performance Comparison: Microsoft And Competitors In Software Industry
On Semiconductor Dips After Truist Cuts Rating to Hold
Trade Desk Analyst Ratings
Micron in Focus as Citi Sees Mixed Data Points on Memory Market at CES
Meta Platforms Analyst Ratings
Alphabet Analyst Ratings
Disney-Fox-Warner Trio to Disband Venu Sports in Wake of Legal Settlement With Fubo
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Take-Two, Xometry: JPMorgan's Bets On Gaming, Manufacturing In 2025
BMO Capital Maintains Outperform on American Electric Power, Lowers Price Target to $100
Dollar Soars To 27-Month Highs, 30-Year Yields Hit 5%, Stocks Tumble As Jobs Report, Oil Spike Darken Fed's Interest Rate Cut Hopes
American Electric Power Analyst Ratings
NXP Semiconductors Receives Upgrade, While AMD Downgraded by Goldman Sachs
Vertex Pharmaceuticals Analyst Ratings
Regeneron Pharmaceuticals Analyst Ratings